Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease

European Journal of Medical Research

Volumn 14, Issue SUPPL.4, 2009, Pages 177-181

  Pabst, S ^a   Theis, B ^a   Gillissen, A ^b   Lennarz, M ^a   Tuleta, I ^a   Nickenig, G ^a   Skowasch, D ^a   Grohe C ^c  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c Ev Lungenklinik Berlin Buch ^*  (Germany)

Author keywords

angiotensin converting enzyme (ACE); COPD; genetics

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED;

ADULT; AGED; ALLELES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 77955484349     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-14-S4-177     Document Type: Article

References (28)

1. COPD exacerbations: definitions and classifications. Burge S, Wedzicha JA, Eur Respir J Suppl 2003 41 46s 53s 12795331 (Pubitemid 36648154)
2. EFRAM Investigators. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Garcia-Aymerich J, Monsá E, Marrades RM, Escarrabill J, Félez MA, Sunyer J, Antá JM, Am J Respir Crit Care Med 2001 164 1002 7 11587986 (Pubitemid 32971648)
3. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA, Thorax 2002 57 847 52 10.1136/thorax.57.10.847 12324669 (Pubitemid 35178607)
4. The development of lung emphysema in cigarette-exposed mice is strain dependant. Guerassimov A, Hoshino Y, Takubo Y, Am J Respir Crit Med 2004 170 974 80 10.1164/rccm.200309-1270OC (Pubitemid 39425693)
5. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. McCloskey SC, Patel BD, Hinchliffe SJ, Reid ED, Wareham NJ, Lomas DA, Am J Respir Cit Care Med 2001 164 1419 24 (Pubitemid 33124020)
6. Chronic obstructive pulmonary disease is associated with the 1055 IL-13 promoter polymorphism. van der Pouw Kraan TC, Küçükaycan M, Bakker AM, Baggen JM, van der Zee JS, Dentener MA, Wouters EF, Verweij CL, Genes Immun 2002 3 436 9 10.1038/sj.gene.6363896 12424628 (Pubitemid 41656545)
7. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Joos L, He JQ, Shepherdson MB, Connett JE, Anthonisen NR, Paré PD, Sandford AJ, Hum Mol Genet 2002 11 569 76 10.1093/hmg/11.5.569 11875051 (Pubitemid 34257493)
8. Matrix metalloproteinase-9 promoter polymorphisms associated with upper lung dominant emphysema. Ito I, Nagai S, Handa T, Muro S, Hirai T, Tsukino M, Mishima M, Am J Respir Crit Care Med 2005 172 1378 82 10.1164/rccm.200506-953OC 16126934 (Pubitemid 43069810)
9. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptyl carboxy peptidase 1). Rigat B, Hubert C, Corvol P, Soubrier F, Nucl Acids Res 1992 20 1433 1348580
10. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F, J Clin Invest 1990 86 1342 6
11. ACE in COPD: a therapeutic target? Forth R, Montgomery H, Thorax 2003 58 556 8 10.1136/thorax.58.7.556 12832663 (Pubitemid 36808122)
12. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Celli BR, MacNee W, ATS/ERS Task force, Eur Respir J 2004 23 932 46 10.1183/09031936.04.00014304 15219010 (Pubitemid 38807371)
13. Interpretive strategies for lung function tests. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J, Eur Respir J 2005 26 948 68 10.1183/09031936.05.00035205 16264058 (Pubitemid 41632054)
14. A simple salting out procedure for extracting DNA from human nucleated cells. Miller SA, Dykes DD, Polesky HF, Nucl Acids Res 1988 16 1215 10.1093/nar/16.3.1215 3344216
15. Corrected normal values for serum ACE by genotyping the deletion/insertion-polymorphism of the ACE-gene. Ruprecht B, Schürmann M, Ziegenhagen MW, vom Bauer E, Meier D, Schlaak M, Müller-Quernheim J, Pneumologie 2001 55 326 32 10.1055/s-2001-15616 11481579
16. From genotypes to genes: Doubling the sample size. Sasieni PD, Biometrics 1997 53 1253 61 10.2307/2533494 9423247 (Pubitemid 28013569)
17. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Cambien F, Poirier O, Lecerf L, et al. Nature 1992 359 641 4 10.1038/359641a0 1328889
18. The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive lung disease. van Suylen RJ, Wouters EF, Pennings HJ, Cheriex EC, van Pol PE, Ambergen AW, Vermelis AM, Daemen MJ, Am J Respir Crit Care Med 1999 159 1791 95 10351920 (Pubitemid 29275044)
19. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Hopkinson NS, Nickol AH, Payne J, Hawe E, Man WD, Moxham J, Montgomery H, Polkey MI, Am J Respir Crit Care Med 2004 170 395 9 10.1164/rccm.200304-578OC 15117739 (Pubitemid 39214613)
20. ACE gene polymorphism and COPD. Gosker HR, Pennings HJ, Schols AMWJ, Am J Respir Crit Care Med 2004 170 572 15331391
21. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ, Am J Respir Crit Care Med 2002 166 633 4 10.1164/rccm.2206004 12204853 (Pubitemid 34971838)
22. Co-morbidity contributes to predict mortality of patients with chronic obstructive lung disease. Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R, Eur Respir J 1997 10 2794 800 10.1183/09031936.97.10122794 9493663 (Pubitemid 28052790)
23. Cardiac troponin I in patients with severe exacerbations of chronic obstructive pulmonary disease. Baillard C, Boussarsar M, Fosse JP, Girou E, Le Toumelin P, Cracco C, Jaber S, Cohen Y, Brochard L, Intensive Care Med 2003 19 584 9 (Pubitemid 36523675)
24. The ACE gene and muscle performance. Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, Martin J, Humphries SE, Montgomery HE, Nature 2000 403 614 10688187 (Pubitemid 30103990)
25. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Montgomery H, Clarkson P, Barnard M, Bell J, Brynes A, Dollery C, Hajnal J, Hemingway H, Mercer D, Jarman P, Marshall R, Prasad K, Rayson M, Saeed N, Talmud P, Thomas L, Jubb M, World M, Humphries S, Lancet 1999 353 541 5 10.1016/S0140-6736(98)07131-1 10028982 (Pubitemid 29078424)
26. Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD. Zhang X, Wang C, Dai H, Lin Y, Zhang J, Respirology 2008 13 683 8 10.1111/j.1440-1843.2008.01325.x 18713090 (Pubitemid 351977595)
27. Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Kanazawa H, Otsuka T, Jirata K, Yoshikawa J, Chest 2002 121 697 701 10.1378/chest.121.3.697 11888948 (Pubitemid 34251430)
28. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Barber JA, Roca J, Ferrer A, Félez MA, Díaz O, Roger N, Rodriguez-Roisin R, Eur Respir J 1997 10 1285 91 10.1183/09031936.97.10061285 9192930 (Pubitemid 27278247)